rs2304355

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001377295.2(GNAT2):​c.-32A>G variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.155 in 1,341,660 control chromosomes in the GnomAD database, including 17,231 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 1515 hom., cov: 31)
Exomes 𝑓: 0.16 ( 15716 hom. )

Consequence

GNAT2
NM_001377295.2 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.214

Publications

29 publications found
Variant links:
Genes affected
GNAT2 (HGNC:4394): (G protein subunit alpha transducin 2) Transducin is a 3-subunit guanine nucleotide-binding protein (G protein) which stimulates the coupling of rhodopsin and cGMP-phoshodiesterase during visual impulses. The transducin alpha subunits in rods and cones are encoded by separate genes. This gene encodes the alpha subunit in cones. [provided by RefSeq, Jul 2008]
GNAT2 Gene-Disease associations (from GenCC):
  • achromatopsia 4
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, G2P
  • GNAT2-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • cone dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • achromatopsia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 1-109612902-T-C is Benign according to our data. Variant chr1-109612902-T-C is described in ClinVar as Benign. ClinVar VariationId is 259742.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.188 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GNAT2NM_001377295.2 linkc.-32A>G 5_prime_UTR_premature_start_codon_gain_variant Exon 2 of 9 ENST00000679935.1 NP_001364224.1
GNAT2NM_001377295.2 linkc.-32A>G 5_prime_UTR_variant Exon 2 of 9 ENST00000679935.1 NP_001364224.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GNAT2ENST00000679935.1 linkc.-32A>G 5_prime_UTR_premature_start_codon_gain_variant Exon 2 of 9 NM_001377295.2 ENSP00000505083.1
GNAT2ENST00000679935.1 linkc.-32A>G 5_prime_UTR_variant Exon 2 of 9 NM_001377295.2 ENSP00000505083.1

Frequencies

GnomAD3 genomes
AF:
0.131
AC:
19984
AN:
152012
Hom.:
1520
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0650
Gnomad AMI
AF:
0.150
Gnomad AMR
AF:
0.137
Gnomad ASJ
AF:
0.205
Gnomad EAS
AF:
0.109
Gnomad SAS
AF:
0.199
Gnomad FIN
AF:
0.157
Gnomad MID
AF:
0.130
Gnomad NFE
AF:
0.159
Gnomad OTH
AF:
0.138
GnomAD2 exomes
AF:
0.153
AC:
38290
AN:
250382
AF XY:
0.156
show subpopulations
Gnomad AFR exome
AF:
0.0626
Gnomad AMR exome
AF:
0.152
Gnomad ASJ exome
AF:
0.206
Gnomad EAS exome
AF:
0.114
Gnomad FIN exome
AF:
0.146
Gnomad NFE exome
AF:
0.158
Gnomad OTH exome
AF:
0.156
GnomAD4 exome
AF:
0.158
AC:
187436
AN:
1189530
Hom.:
15716
Cov.:
17
AF XY:
0.159
AC XY:
96221
AN XY:
605102
show subpopulations
African (AFR)
AF:
0.0616
AC:
1745
AN:
28336
American (AMR)
AF:
0.150
AC:
6677
AN:
44406
Ashkenazi Jewish (ASJ)
AF:
0.205
AC:
5015
AN:
24420
East Asian (EAS)
AF:
0.0951
AC:
3657
AN:
38446
South Asian (SAS)
AF:
0.194
AC:
15722
AN:
80856
European-Finnish (FIN)
AF:
0.149
AC:
7712
AN:
51712
Middle Eastern (MID)
AF:
0.127
AC:
664
AN:
5234
European-Non Finnish (NFE)
AF:
0.160
AC:
137984
AN:
864602
Other (OTH)
AF:
0.160
AC:
8260
AN:
51518
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
8231
16462
24692
32923
41154
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4370
8740
13110
17480
21850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.131
AC:
19976
AN:
152130
Hom.:
1515
Cov.:
31
AF XY:
0.132
AC XY:
9810
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.0649
AC:
2693
AN:
41508
American (AMR)
AF:
0.137
AC:
2102
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.205
AC:
713
AN:
3470
East Asian (EAS)
AF:
0.108
AC:
559
AN:
5168
South Asian (SAS)
AF:
0.198
AC:
957
AN:
4826
European-Finnish (FIN)
AF:
0.157
AC:
1664
AN:
10582
Middle Eastern (MID)
AF:
0.126
AC:
37
AN:
294
European-Non Finnish (NFE)
AF:
0.159
AC:
10820
AN:
67964
Other (OTH)
AF:
0.139
AC:
294
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
882
1763
2645
3526
4408
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
240
480
720
960
1200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.154
Hom.:
3342
Bravo
AF:
0.126
Asia WGS
AF:
0.151
AC:
526
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Achromatopsia 4 Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.72
CADD
Benign
2.1
DANN
Benign
0.78
PhyloP100
-0.21
PromoterAI
-0.034
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2304355; hg19: chr1-110155524; COSMIC: COSV107411352; COSMIC: COSV107411352; API